|
Volumn 106, Issue 6, 2002, Pages 679-684
|
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
|
Author keywords
Atherosclerosis; Cardiovascular diseases; Diabetes mellitus; Inflammation; Risk factors
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
C REACTIVE PROTEIN;
GELATINASE B;
INTERLEUKIN 6;
PLACEBO;
ROSIGLITAZONE;
ADULT;
AGED;
ARTICLE;
ATHEROGENESIS;
ATHEROSCLEROTIC PLAQUE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEART INFARCTION;
HUMAN;
INFLAMMATORY DISEASE;
INSULIN RESISTANCE;
LEUKOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
STATISTICAL SIGNIFICANCE;
UNSTABLE ANGINA PECTORIS;
BIOLOGICAL MARKERS;
BODY WEIGHT;
C-REACTIVE PROTEIN;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
INTERLEUKIN-6;
LEUKOCYTE COUNT;
MALE;
MATRIX METALLOPROTEINASE 9;
MIDDLE AGED;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
RISK FACTORS;
THIAZOLES;
THIAZOLIDINEDIONES;
TRANSCRIPTION FACTORS;
|
EID: 0037031267
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.0000025403.20953.23 Document Type: Article |
Times cited : (868)
|
References (28)
|